|

AST-201 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Aptamer Sciences, Inc.1

Indications

  • Liver Disease1
  • Neoplasms1
  • Carcinoma, Non-Small-Cell Lung1
  • Liver Neoplasms1
  • Carcinoma, Hepatocellular1

Other1 trial

A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.